HLA-B56 antigen

Also Known As:

HLA B*56; HLA Bw56; HLA-B*56; HLA-B*5614; HLA-B*56:14 antigen; HLA-Bw56

Networked: 4 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Carbohydrates: 22023
- Glycoconjugates: 1353
  - Glycoproteins: 24834
    - Membrane Glycoproteins: 2252
      - Histocompatibility Antigens Class I: 1944
        HLA-B Antigens: 1869
        HLA-B56 antigen: 4
Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Glycoproteins: 24834
    - Membrane Glycoproteins: 2252
      - Histocompatibility Antigens Class I: 1944
        HLA-B Antigens: 1869
        HLA-B56 antigen: 4
  - Membrane Proteins: 10078
    - Membrane Glycoproteins: 2252
      - Histocompatibility Antigens Class I: 1944
        HLA-B Antigens: 1869
        HLA-B56 antigen: 4
Biological Factors: 2472
- Antigens: 143924
  - Surface Antigens: 5813
    - Histocompatibility Antigens: 1132
      - HLA Antigens: 8934
        HLA-B Antigens: 1869
        HLA-B56 antigen: 4
      - Histocompatibility Antigens Class I: 1944
        HLA-B Antigens: 1869
        HLA-B56 antigen: 4
  - Isoantigens: 1221
    - Histocompatibility Antigens: 1132
      - HLA Antigens: 8934
        HLA-B Antigens: 1869
        HLA-B56 antigen: 4
      - Histocompatibility Antigens Class I: 1944
        HLA-B Antigens: 1869
        HLA-B56 antigen: 4

Experts

1.	Barratt, Daniel T: 1 article (01/2019)
2.	Gabb, Genevieve M: 1 article (01/2019)
3.	Ilyas, Fahmida: 1 article (01/2019)
4.	Moore, Kylies: 1 article (01/2019)
5.	Phillips, Elizabeth J: 1 article (01/2019)
6.	Somogyi, Andrew A: 1 article (01/2019)
7.	Chumworathayi, Pansu: 1 article (05/2016)
8.	Khunarkornsiri, Usanee: 1 article (05/2016)
9.	Kongpan, Thachanan: 1 article (05/2016)
10.	Konyoung, Parinya: 1 article (05/2016)

Related Diseases

1.	Cicatrix (Scar) 05/01/2016 - "Certain alleles of HLA, particularly HLA-B*56:02, were significantly associated with phenytoin-related SCAR in the study population."
2.	Drug Hypersensitivity Syndrome 01/01/2019 - "Phenytoin drug reaction with eosinophilia and systemic symptoms (DRESS) in 3 Aboriginal Australians positive for HLA-B56:02 has been previously reported. " 01/01/2019 - "High and variable population prevalence of HLA-B56:02 in indigenous Australians and relation to phenytoin-associated drug reaction with eosinophilia and systemic symptoms."
3.	Genetic Predisposition to Disease (Genetic Predisposition) 04/01/2013 - "It is concluded that HLA-B56, B70 alleles seem to be characterized by the genetic susceptibility to leukemia and may be served as risk markers for leukemia occurrence, while the HLA-A03, A30, B13, B44, B61, DRB107, DRB1*15 can be considered as genetic indicators for resistance of leukemia."
4.	Leukemia 04/01/2013 - "The results indicated that as compared with the control group, the allele frequencies of HLA-B56 (0.56%), B70 (0.24%) obviously increased (RR = 2.2546, 6.2598, χ(2) = 5, 5.98, P < 0.05), while the allele frequencies of HLA-A03 (3.45%), A30 (4.86%), B13 (8.75%), B44 (3.25%), B61* (5.70%), DRB107 (8.23%), DRB115 (14.21%) obviously decreased in patients with leukemia (RR = 0.5889, 0.7187, 0.7359, 0.5713, 0.7127, 0.6242, 0.7976, χ(2) = 19.23, 9.82, 14.33, 20.48, 11.99, 33.21, 11.56, P < 0.01). " 04/01/2013 - "It is concluded that HLA-B56, B70 alleles seem to be characterized by the genetic susceptibility to leukemia and may be served as risk markers for leukemia occurrence, while the HLA-A03, A30, B13, B44, B61, DRB107, DRB1*15 can be considered as genetic indicators for resistance of leukemia."
5.	Crohn Disease (Crohn's Disease) 01/01/2012 - "High risk of developing Crohn's disease among residents of Moscow associated with groups of alleles of HLA B41, HLA-B56, HLA-Cw05, HLA-Cw08, HLA-DRV101, HLA-DRV111, HLA-DQV104, and the presence of specificity of HLA-DQV105 can be considered as a factor of resistance to the development of BC. "

Related Drugs and Biologics

1.	Phenytoin (Dilantin)
2.	HLA-B Antigens (HLA-B)
3.	HLA-A Antigens (HLA-A)
4.	A-factor (Streptomyces)